Issues lobbied + lobbyists
HCR — Health Issues
Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI.
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TAX — Taxation/Internal Revenue Code
Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
HOU — Housing
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
EDU — Education
Workforce Development
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TAR — Tariff (miscellaneous tariff bills)
Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
SPO — Sports/Athletics
Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
CHM — Chemicals/Chemical Industry
PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl] (PFAS) type(s) of substances used in medical devices
Lobbyists: ms ALLISON HOBBS GILES (covered position: Vice President of Global Government Affairs)
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE